What we're reading, February 12, 2016: the former Kentucky governor is looking to block the current governor's plans to dismantle Kynect; Senator Orrin Hatch speaks out against Medicare negotiation of drug prices; and the link between Zika and microcephaly is growing stronger.
In Kentucky, the former governor, Steve Beshear, is launching an effort to thwart the efforts of the new Republican governor, Matt Bevin, who is starting the process to dismantle the state’s health insurance exchange, Kynect. Beshear announced that an online campaign will educate voters about what is happening to healthcare in Kentucky, according to ABC News. During Beshear’s time as governor, he issued an executive order to expand Medicaid and establish the state exchange.
While some presidential hopefuls, like Hillary Clinton, Bernie Sanders, and Donald Trump, are calling for Medicare to have the ability to negotiate drug prices, Senator Orrin Hatch is firmly against it, noting that Medicare negotiation wouldn’t be “a big saver.” Washington Examiner reported that the senator asked HHS Secretary Sylvia M. Burwell if her agency had worked with the president on an executive order that would allow the government to negotiate prices. Hatch is worried the president would issue such an executive order, which Hatch called a “violation of the law.”
The link between the Zika virus and microcephaly is growing stronger, CDC Director Tom Frieden, MD, testified before the Senate Appropriations Committee. Studies of babies that died within 24 hours found they had microcephaly, according to the Washington Times. Dr Frieden and Anthony Fauci, MD, infectious disease director at the National Institutes of Health, asked lawmakers to approve the president’s request for emergency funding to fight Zika.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More